
A Mutation-Agnostic Approach to Progeria Gene Therapy
A new preprint study demonstrates a mutation-agnostic base-editing platform that selectively disrupts the toxic mechanism behind Hutchinson-Gilford progeria syndrome. By targeting shared disease pathways rather than individual genetic errors, this approach provides a proof-of-concept for future RNA-based treatments in progeroid diseases.































